Loading…
Based on limited metadata with no full letter text available, the FDA issued a Warning Letter to Great American Marketing Company on February 16, 2018, regarding products classified as "Other." Without access to the subject line or specific violation details, the exact nature of the regulatory concerns cannot be determined from the available information. The issuing office is also not specified in the metadata provided. To understand the specific violations and regulatory requirements at issue, the complete Warning Letter text would be needed.